Table 1 Comparisons of HPV status and clinical variables.
From: Human Papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients
HPV (+) n = 15 | HPV (-) n = 36 | P value | |
|---|---|---|---|
Age | 48.13 ± 12.35 | 55.36 ± 13.5 | 0.86 |
Histology | 0.489 | ||
Ductal | 15 | 33 | |
Lobular | 0 | 3 | |
Clinical stage | 0.206 | ||
Early | 5 | 7 | |
Advance | 7 | 26 | |
Not classificated | 3 | 3 | |
Estrogen receptors | 0.342 | ||
Negative | 7 | 13 | |
Positive | 5 | 8 | |
Not done | 3 | 15 | |
Progesterone receptors | 0.190 | ||
Negative | 6 | 15 | |
Positive | 6 | 6 | |
Not done | 3 | 15 | |
Tumor size | 0.008 | ||
< 2 cm. | 5 (33.33%) | 5 (13.88%) | |
2 – 4 cm. | 9 (60.00%) | 12 (33.33%) | |
> 4 cm. | 1 (6.66%) | 19 (52.77%) |